Search Results - "Voisin, Anne Laure"

Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment by Belkhir, Rakiba, Burel, Sébastien Le, Dunogeant, Laetitia, Marabelle, Aurélien, Hollebecque, Antoine, Besse, Benjamin, Leary, Alexandra, Voisin, Anne-Laure, Pontoizeau, Clémence, Coutte, Laetitia, Pertuiset, Edouard, Mouterde, Gaël, Fain, Olivier, Lambotte, Olivier, Mariette, Xavier

“…Immune checkpoint inhibitors (ICIs) targeting cytotoxic T-lymphocyte-associated protein 4 and programmed cell death protein 1 (PD-1) have demonstrated improved…”
Get more information

Impact of aging on immune-related adverse events generated by anti–programmed death (ligand)PD-(L)1 therapies by Baldini, Capucine, Martin Romano, Patricia, Voisin, Anne-Laure, Danlos, François-Xavier, Champiat, Stéphane, Laghouati, Salim, Kfoury, Maria, Vincent, Hélène, Postel-Vinay, Sophie, Varga, Andreea, Vuagnat, Perrine, Ribrag, Vincent, Mezquita, Laura, Besse, Benjamin, Hollebecque, Antoine, Lambotte, Olivier, Michot, Jean-Marie, Soria, Jean-Charles, Massard, Christophe, Marabelle, Aurélien

“…Aging is an important risk factor for cancers and is associated with poor prognosis. Weakness of the immune system, also called immunosenescence may occur with…”
Get full text

Immune checkpoint inhibitor–associated sarcoidosis: A usually benign disease that does not require immunotherapy discontinuation by Chanson, Noémie, Ramos-Casals, Manuel, Pundole, Xerxes, Suijkerbuijk, Karijn, José de Barros e Silva, Milton, Lidar, Merav, Benesova, Karolina, Leipe, Jan, Acar-Denizli, Nihan, Pradère, Pauline, Michot, Jean-Marie, Voisin, Anne- Laure, Suárez-Almazor, Maria E., Radstake, Timothy R.D., Fernandes Moça Trevisani, Virginia, Schulze-Koops, Hendrik, Melin, Audrey, Robert, Caroline, Mariette, Xavier, Baughman, Robert P., Lambotte, Olivier, Ramos-Casals, Manuel, Mariette, Xavier, Lambotte, Olivier, Kostine, Marie, Khamashta, Munther A., Calabrese, Leonard, Suárez-Almazor, Maria, Baldini, Chiara, Bingham, Clifton O., Gottenberg, Jacques-Eric, Radstake, Timothy R.D., Schaeverbeke, Thierry, Schulze-Koops, Hendrik, Brito-Zerón, Pilar, Flores-Chávez, Alejandra, Acar-Denizli, Nihan

“…To analyse the clinical patterns of sarcoidosis triggered by immune checkpoint inhibitors (ICIs) in patients with cancer. The ImmunoCancer International…”
Get full text

Immune-related eosinophilia induced by anti-programmed death 1 or death-ligand 1 antibodies by Bernard-Tessier, Alice, Jeanville, Priscilla, Champiat, Stéphane, Lazarovici, Julien, Voisin, Anne-Laure, Mateus, Christine, Lambotte, Olivier, Annereau, Maxime, Michot, Jean-Marie

“…Checkpoints inhibitors anti-programmed death 1 (PD1) and anti-programmed death ligand 1 (PD-L1) restore immunity against tumour. By their mechanism of action,…”
Get full text

Significance of Immune-related Lipase Increase Induced by Antiprogrammed Death-1 or Death Ligand-1 Antibodies: A Brief Communication by Michot, Jean-Marie, Ragou, Parvady, Carbonnel, Franck, Champiat, Stéphane, Voisin, Anne-Laure, Mateus, Christine, Lambotte, Olivier, Annereau, Maxime

“…Antiprogrammed death-1 (anti-PD1) and antiprogrammed death ligand-1 (anti-PD-L1) antibodies are effective checkpoint inhibitors that stimulate the immune…”
Get full text

Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease by Danlos, François-Xavier, Voisin, Anne-Laure, Dyevre, Valérie, Michot, Jean-Marie, Routier, Emilie, Taillade, Laurent, Champiat, Stéphane, Aspeslagh, Sandrine, Haroche, Julien, Albiges, Laurence, Massard, Christophe, Girard, Nicolas, Dalle, Stéphane, Besse, Benjamin, Laghouati, Salim, Soria, Jean-Charles, Mateus, Christine, Robert, Caroline, Lanoy, Emilie, Marabelle, Aurélien, Lambotte, Olivier

“…Patients with autoimmune or inflammatory disease (AID) are susceptible to immune-related adverse events (irAEs) when treated with immune check-point inhibitors…”
Get full text

Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy by Ferrara, Roberto, Naigeon, Marie, Auclin, Edouard, Duchemann, Boris, Cassard, Lydie, Jouniaux, Jean-Mehdi, Boselli, Lisa, Grivel, Jonathan, Desnoyer, Aude, Mezquita, Laura, Texier, Matthieu, Caramella, Caroline, Hendriks, Lizza, Planchard, David, Remon, Jordi, Sangaletti, Sabina, Proto, Claudia, Garassino, Marina C, Soria, Jean-Charles, Marabelle, Aurelien, Voisin, Anne-Laure, Farhane, Siham, Besse, Benjamin, Chaput, Nathalie

“…CD28, CD57, and KLRG1 have been previously identified as markers of T-cell immunosenescence. The impact of immunosenescence on anti-PD(L)-1 (ICI) or…”
Get full text

Infectious complications in patients treated with immune checkpoint inhibitors by Karam, Jean-Denis, Noel, Nicolas, Voisin, Anne-Laure, Lanoy, Emilie, Michot, Jean-Marie, Lambotte, Olivier

“…Immune checkpoint inhibitor (ICI) antibodies constitute a new generation of cancer treatments, associated with immune-related adverse events (irAEs). A…”
Get full text

Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis by Le Burel, Sébastien, Champiat, Stéphane, Mateus, Christine, Marabelle, Aurélien, Michot, Jean-Marie, Robert, Caroline, Belkhir, Rakiba, Soria, Jean-Charles, Laghouati, Salim, Voisin, Anne-Laure, Fain, Olivier, Mékinian, Arsène, Coutte, Laetitia, Szwebel, Tali-Anne, Dunogeant, Laetitia, Lioger, Bertrand, Luxembourger, Cécile, Mariette, Xavier, Lambotte, Olivier

“…The growing use of immune checkpoint inhibitors (ICIs) is associated with the occurrence of immune-related adverse events (irAEs). Few data are published on…”
Get full text

The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry by Ruste, Valentine, Goldschmidt, Vincent, Laparra, Ariane, Messayke, Sabine, Danlos, Francois-Xavier, Romano-Martin, Patricia, Champiat, Stéphane, Voisin, Anne-Laure, Baldini, Capucine, Massard, Christophe, Laghouati, Salim, Marabelle, Aurélien, Lambotte, Olivier, Michot, Jean-Marie

“…Immune-related adverse events (irAEs) remain generally unpredictable, and severe irAEs remain challenging to detect early and manage. Very severe (grade IV–V)…”
Get full text

Occurrences and Outcomes of Immune Checkpoint Inhibitors-Induced Vitiligo in Cancer Patients: A Retrospective Cohort Study by Babai, Samy, Voisin, Anne-Laure, Bertin, Célia, Gouverneur, Amandine, Le-Louet, Hervé

“…Background The use of immune checkpoint inhibitors (ICI) in melanoma and non-small cell lung cancer patients is associated with the onset of vitiligo. However,…”
Get full text

Prevalence and Clinical Patterns of Ocular Complications Associated With Anti-PD-1/PD-L1 Anticancer Immunotherapy by Bitton, Karen, Michot, Jean-Marie, Barreau, Emmanuel, Lambotte, Olivier, Haigh, Oscar, Marabelle, Aurélien, Voisin, Anne-Laure, Mateus, Christine, Rémond, Anne-Laure, Couret, Chloé, Champiat, Stéphane, Labetoulle, Marc, Rousseau, Antoine

“…Immune checkpoint inhibitors (ICI) targeting the programmed cell death protein 1 (PD-1), or its ligand PD-L1, are the mainstay of metastatic cancer treatment…”
Get full text

Onset of connective tissue disease following anti-PD1/PD-L1 cancer immunotherapy by Le Burel, Sébastien, Champiat, Stéphane, Routier, Emilie, Aspeslagh, Sandrine, Albiges, Laurence, Szwebel, Tali-Anne, Michot, Jean-Marie, Chretien, Pascale, Mariette, Xavier, Voisin, Anne-Laure, Lambotte, Olivier

Get more information

Analysis of the association between prospectively collected immune-related adverse events and survival in patients with solid tumor treated with immune-checkpoint blockers, taking into account immortal-time bias by Kfoury, Maria, Najean, Marie, Lappara, Ariane, Voisin, Anne-Laure, Champiat, Stéphane, Michot, Jean-Marie, Laghouati, Salim, Robert, Caroline, Besse, Benjamin, Soria, Jean-Charles, Lambotte, Olivier, Massard, Christophe, Marabelle, Aurélien, Texier, Matthieu

“…•The association between immune-related adverse events (irAEs) and survival in patients with solid tumor is still unclear.•Published studies not dealing…”
Get full text

Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study by Delanoy, Nicolas, Michot, Jean-Marie, Comont, Thibault, Kramkimel, Nora, Lazarovici, Julien, Dupont, Romain, Champiat, Stéphane, Chahine, Claude, Robert, Caroline, Herbaux, Charles, Besse, Benjamin, Guillemin, Aude, Mateus, Christine, Pautier, Patricia, Saïag, Philippe, Madonna, Emanuela, Maerevoet, Marie, Bout, Jean-Christophe, Leduc, Charlotte, Biscay, Pascal, Quere, Gilles, Nardin, Charlée, Ebbo, Mikael, Albigès, Laurence, Marret, Grégoire, Levrat, Virginie, Dujon, Cécile, Vargaftig, Jacques, Laghouati, Salim, Croisille, Laure, Voisin, Anne-Laure, Godeau, Bertrand, Massard, Christophe, Ribrag, Vincent, Marabelle, Aurélien, Michel, Marc, Lambotte, Olivier

“…Anti-programmed cell death 1 (PD-1) and anti-programmed cell death ligand 1 (PD-L1) antibodies are novel immunotherapies for cancer that can induce…”
Get full text

Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1 by Michot, Jean-Marie, Fusellier, Mathilde, Champiat, Stephane, Velter, Charles, Baldini, Capucine, Voisin, Anne-Laure, Danlos, Francois-Xavier, Dakdouki, Yolla El, Annereau, Maxime, Mariette, Xavier, Robert, Caroline, Cherif, Khadija, Marabelle, Aurélien, Mateus, Christine, Lambotte, Olivier

Get more information

The 2016–2019 ImmunoTOX assessment board report of collaborative management of immune-related adverse events, an observational clinical study by Michot, Jean-Marie, Lappara, Ariane, Le Pavec, Jérôme, Simonaggio, Audrey, Collins, Michael, De Martin, Eléonora, Danlos, François-Xavier, Ammari, Samy, Cauquil, Cécile, Ederhy, Stéphane, Barreau, Emmanuel, Belkhir, Rakiba, Berdelou, Amandine, Lazarovici, Julien, Chanson, Philippe, Izzedine, Hassan, Seferian, Andrei, Le Pajolec, Christine, Baldini, Capucine, Martin-Romano, Patricia, Mariette, Xavier, Robert, Caroline, Besse, Benjamin, Hollebecque, Antoine, Varga, Andrea, Laghouati, Salim, Mateus, Christine, Voisin, Anne-Laure, Soria, Jean-Charles, Massard, Christophe, Marabelle, Aurélien, Champiat, Stéphane, Lambotte, Olivier

“…We investigated the activities of an ImmunoTOX board, an academic, multidisciplinary group of oncologists and organ specialists that adopts a real-life,…”
Get full text

Myocarditis with Immune Checkpoint Blockade by Ederhy, Stéphane, Voisin, Anne-Laure, Champiat, Stéphane, Caio, Giacomo, Moslehi, Javid J, Johnson, Douglas B, Sosman, Jeffrey A

“…To the Editor: In their report on cardiotoxicity associated with immune checkpoint blockade, Johnson et al. (Nov. 3 issue) 1 describe two patients with…”
Get full text

Outcomes of patients with cancer and sarcoid-like granulomatosis associated with immune checkpoint inhibitors: A case–control study by Cabanié, Charlotte, Ammari, Samy, Hans, Sophie, Pobel, Cedric, Laparra, Ariane, Danlos, Francois-Xavier, Chanson, Noémie, Dolidon, Samuel, Seban, Romain, Voisin, Anne-Laure, Pautier, Patricia, Romano-Martin, Patricia, Even, Caroline, Baldini, Capucine, Besse, Benjamin, Albiges, Laurence, Boutros, Celine, Routier, Emilie, Balleyguier, Corinne, De Montpreville, Vincent T., Champiat, Stéphane, Massard, Christophe, Robert, Caroline, Marabelle, Aurélien, Mateus, Christina, Lambotte, Olivier, Le Pavec, Jérôme, Michot, Jean-Marie

“…Sarcoid-like granulomatosis (SLG) reaction caused by immunotherapy remains poorly understood. This study aims to investigate the outcome of patients with…”
Get full text

Letter responds to the comment in ‘immune thrombocytopenia of haematological immune-related adverse events in cancer immunotherapy: Most and mighty’ by Michot, Jean-Marie, Lazarovici, Julien, Tieu, Ashley, Champiat, Stéphane, Voisin, Anne-Laure, Ebbo, Mikael, Godeau, Bertrand, Michel, Marc, Ribrag, Vincent, Lambotte, Olivier

Get full text